Advocates, Medical Professionals, Pediatric, Physician, Researchers, Advocacy, Research & Drug Development, Publication, Medical Affairs, Research, December 13, 2024 How To Advocate For Rare Disease-Related Policies: A Guide for Professionals Involved in Diagnosis, Care, or Research of Rare Diseases
Advocates, Medical Professionals, Researchers, Regulatory, Research & Drug Development, PDF, Publication, Policy, October 17, 2022 FDA’s Flexibility in Regulating Therapies
Advocates, Medical Professionals, Patient Organizations, Students & Volunteers, Advocacy, Legislative Advocacy, Research & Drug Development, PDF, Publication, Education, Policy, Study on Orphan Drug Costs & Use
Advocates, Patient Organizations, Researchers, Advocacy, Research & Drug Development, PDF, Publication, Education, Policy, Orphan Drug Costs & Expenditures
Advocates, Patient & Caregiver, Patient Organizations, Students & Volunteers, Advocacy, Research & Drug Development, Understanding Rare Disease, Infographic, PDF, Publication, Education, NORD RareInsights® 5 Myths About the ODA
Advocates, Patient Organizations, Researchers, Advocacy, Regulatory, Research & Drug Development, Collection, Publication, Education, Policy, Orphan Drug Trends in the United States 2018
Advocates, Patient Organizations, Researchers, Advocacy, Research & Drug Development, PDF, Publication, Education, Policy, Orphan Drugs in the United States: Exclusivity, Pricing and Treated Populations
Advocates, Patient & Caregiver, Patient Organizations, COVID-19, PDF, Publication, Education, NORD RareInsights® COVID-19 Community Survey Report
